What happens when many more breast cancer patients are suddenly eligible for services that are already in high demand? A much larger pool of patients...
When the pink's packed away, and screening isn't top of mind come November, many of the women who have flocked to their local breast centers to get...
High-risk breast programs increase rates of early cancer detection, improving patient outcomes, lowering the cost of care and engaging patients in...
Today kicks off the National Society of Genetic Counselors Annual Conference in Chicago, and we are so excited at CancerIQ to welcome the incredible...
Drs. Diane Stoller and Suzanne Hoekstra were so adamant about bringing cancer genetic testing to their community that they spearheaded a high-risk...
Now that we're transitioning from Ovarian Cancer Awareness Month to Breast Cancer Awareness Month, I’d like to shine the spotlight on the incredible...
In honor of #PrevivorDay, I’d like to celebrate the people who’ve taken action to learn their cancer risk and the providers who’ve equipped them to...
I’m incredibly proud that CancerIQ is officially a member of the CancerX Moonshot initiative, an innovative partnership led by the Digital Medicine...
How NCCN Guidelines and the Tyrer-Cuzick Lifetime Model differ and why programs are missing patients.
OSF HealthCare, one of our longstanding partners, recently enhanced their program with a hybrid HL7 and FHIR integration with CancerIQ to integrate...
The changing season is the perfect time for health systems to upgrade their screening programs to support cancer prevention and early detection...
The average breast program provides one-size-fits-all preventive care that fails to meet the needs of the 1 in 10 women, like Jill Martin, with the...
The time for bigger and bolder is now, and we are humbled by the potential impact CancerIQ can have on patients and their families in the next...
At ASCO, I saw a lot of new innovations that are accelerating the urgency to change how we think about genomics in cancer prevention and treatment.
Our latest offerings underscore our commitment to the genetics community, high-risk program outcomes, and continued innovation in precision...
This year we were excited to see growing momentum around personalized prevention & early detection of cancer. Read on for our top 3 three takeaways...
Your curated February 2023 articles from trusted sources, keeping you up-to-date on cancer prevention, precision medicine & oncology, health equity,...
Your curated January 2023 articles from trusted sources, keeping you up-to-date on cancer prevention, precision medicine & oncology, health equity, &...
One of the greatest sources of untapped revenue lies in oncology, where an unmet need for cancer prevention also promises to drive innovation...
Your curated December 2022 articles from trusted sources, keeping you up-to-date on cancer prevention, precision medicine & oncology, health equity,...
CancerIQ data shows 2 in 5 patients who undergo comprehensive cancer risk assessment and genetic testing require a change in medical management.
Your curated November 2022 articles from trusted sources, keeping you up-to-date on cancer prevention, precision medicine & oncology, health equity,...
Last week, the CancerIQ team & I headed to HLTH 2022, the NSGC Annual Conference, & the AACR Special Conference. I'm feeling inspired and with a full...
Your curated October 2022 articles from trusted sources, keeping you up-to-date on cancer prevention, precision medicine & oncology, health equity,...
Breast center providers including mammography techs, nurses, and clinicians, as well as the patients they serve deserve a tool that helps them follow...
What separates the genetics programs that succeed from those that don’t? Learn how your health system can address this gap by working with CancerIQ...
Your curated September 2022 articles from trusted sources, keeping you up-to-date on cancer prevention, precision medicine & oncology, health equity,...
The changing season is the perfect time for health systems to upgrade their screening programs to support cancer prevention and early detection...
Genetic counselors are an invaluable resource for early cancer detection and precision cancer prevention. Today this limited workforce is focused on...
Your curated August 2022 articles from trusted sources, keeping you up-to-date on cancer prevention, precision medicine & oncology, health equity,...
Your curated July 2022 articles from trusted sources, keeping you up-to-date on cancer prevention, precision medicine & oncology, health equity, and...
Don't wait until the end of the month for stories like these. Stay up-to-date with the latest in precision prevention news. Follow CancerIQ on social...
In a recent webinar hosted by the Association of Cancer Executives, CancerIQ’s Senior Vice President of Commercial Strategy, John Hansel, discussed...
Genomics has an established benefit in precision cancer care for patients and providers alike – but its positive financial impact on your health...
Health systems are introducing high-risk breast programs to help high-risk patients access the preventive care they need to manage risk of cancer.
There are many clear benefits to building a genetics program focused on identifying and treating patients with a high risk of a cancer diagnosis.
At the 10th Annual Clinical Cancer Genetics & Genomics Conference Haibo Lu and Matt Valin presented the challenges of high-risk cancer program design.
The CancerIQ product suite is an end-to-end solution, genetic history data gathering to supporting the management of high-risk care plans.
CancerIQ joined leading experts in breast health at the National Consortium of Breast Centers’ 31st Annual Interdisciplinary Breast Center...
Dr. Olopade shared the promise of precision health to transform cancer outcomes for the better — so long as key informatics challenges can be...
As the nation honors Black History Month and National Cancer Prevention Month, experts are calling attention to disparities in screening access and...
2021 prompted us to define the “new normal” in every facet of our lives, and cancer care was no exception.
Millions of women with a family history of breast or ovarian cancer have yet to undergo genetic testing despite lifetime risk being 7x higher than...
Health systems with top-tier high-risk breast program increase early detection, prevent costly late-stage cancer care, and improve survival rates.
At HIMSS21, AHEAD Medical Director Candace Westgate, DO, explained how technology helped Adventist Health bring genomics to patients systemwide.
NCBC 2021: Breast centers expedited the adoption of virtual care to better serve high-risk patients missing appointments due to COVID-19.
Top takeaways from the ACCC 2021 Virtual meeting
Digital health innovation is messy, gritty, iterative, and most importantly, it takes place across the healthcare ecosystem.
President’s Cancer Panel: 5 takeaways on breast cancer screening, genetic testing access, and widening adoption of new technology.
President’s Cancer Panel: Why screening and testing are paramount as cancer diagnoses are down nearly 50% during the pandemic.
CancerIQ, an enterprise precision health platform for cancer, has formed a network of trusted genetic labs to streamline and inform the genetic test...
Community centers lose revenue potential from patient leakage, up to $650,000, on average, per patient. But what if there were a way to plug those...
Learn how to transition to telehealth and the steps Adventist's AHEAD Program took to achieve 133% of budgeted visit volume during the shutdowns.
In no other specialty is the evidence supporting Precision Health more clear than in Oncology. The result is early detection and the best possible...
Patient-centric best practices for operating genetics and high-risk cancer programs in the age of COVID-19.
Limiting access to care might reduce the risk of contracting the novel coronavirus, but at the same time increases the risk of spiking late-stage...
Best Practices from CancerIQ partners engaging patients in virtual genetics and high-risk programs amidst a pandemic.
Fewer Americans have been getting cancer screenings since COVID-19 restrictions were put into place. To address concerns, Dr. Westgate and her team...
CancerIQ addresses many of the concerns that are top of mind for the 55 cancer programs Advisory Board surveyed to see how COVID-19 has changed their...
Why it is vital to keep genetics programs active during COVID-19 shutdowns and how virtual screenings can keep us ahead of cancer.
Switching from in-person visits to phone/video calls can feel a little bit daunting. To help your transition, we met with our client Dignity Health...
Leverage CancerIQ to deliver Telehealth Services Over the Next 90 Days
CancerIQ helped CHRISTUS identify more high-risk cancer patients, generating downstream revenue while improving care.
At the HIMSS 2020 conference, join Dr. Candace Westgate and Dr. Zanone for a presentation on identifying and managing patients at risk for cancer...
You need financial justification for your genetic services and cancer risk assessment. Learn why and how to calculate your ROI in the educational...
Catch up on best practices from this Association of Cancer Executives Annual Meeting best practices workshop
Dr. Candace Westgate, Medical Director at Adventist Health, shares how she leveraged technology to reach her population health efforts at IHI 2019.
This post covers why you should attend this ACE 2020 best practices workshop to improve your access to genetic counseling and testing services.
How you can meet your genetic counseling and testing goals aligned with 2020 Commission on Cancer Standards.
CEO Feyi Olopade looks back on a great 2019 - and offers words for an even better 2020.
Primary care is expanding their role in genetics. This post outlines 3 ways Primary Care can impact genetic screening.
In this blog post, we cover key lessons learned after integrating genetics into an EHR.
Feyi Olopade was named to Crain's 40 under 40 list. While she is doing great things at CancerIQ, her rescue dog, Ricky, stole the spotlight.
Marin General Hospital identified more at-risk and high-risk patients with CancerIQ to maintain its commitment to breast health.
Increase patient uptake of high-risk services with smarter assessment software and a point-of-care scheduling model.
How one Chicago-based community medical center built a profitable and high-capacity cancer risk assessment program in partnership with CancerIQ.
Matthew Knowles' revelations, combined with growing research, further builds the case for broadened cancer screening and testing guidelines.
A high-risk program in a busy breast center leveraged CancerIQ to grow referrals, scale counseling services, and prove program value.
Learn how primary care physicians leverage technology to meet the USPSTF BRCA recommendations to provide risk assessment to more women in routine...
The USPSTF recommends primary care physicians use validated familial risk assessment tools before referring patients for genetic counseling and...
Discover three ways breast imaging centers can successfully implement genetic counseling and testing at the point of care.
From the association of cancer executives, here are the eight tips for health systems to make the most of their valuable genetic counselor resources.
Innovative solutions that make breast cancer risk assessment and genetics more accessible are helping systems address the Triple Aim.
Scale the cancer risk assessment program to identify more high-risk patients, increase service capacity, and manage care over time.
Make a good risk assessment program great using smarter assessment tools and leveraging genetics-trained clinicians.
3 takeaways from how OSF Healthcare overcame key challenges in quality with CancerIQ's point-of-care scheduling model.
On World Cancer Day - Black History Month we reflect on how African-American women are less likely to undergo genetic counseling.
Learn how a cancer genetic counseling program was able to convert more referrals, improve productivity, and drive downstream revenues.
Software screening solutions remove the obstacles and paperwork that impede breast cancer risk assessment workflows.
90% of women with a hereditary risk of breast cancer have yet to be identified. CancerIQ can help breast centers start, run and grow a high-risk...
Three ways genetic counselors can help referring physicians identify patients at high-risk for HBOC